View in EDS

Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.

Saved in:
Bibliographic Details
Title: Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
Authors: Corral J; Clínica Universidad de Navarra, Madrid, 28027, Spain., Mok TS; State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, PR China., Nakagawa K; Kindai University Hospital, Osaka, 589-8511, Japan., Rosell R; Catalan Institute of Oncology, Barcelona, Spain., Lee KH; Chungbuk National University Hospital, Cheongju, Korea., Migliorino MR; Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, 00152, Italy., Pluzanski A; The Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology, Warsaw, 02-781, Poland., Linke R; SFJ Pharmaceuticals®, Pleasanton, CA 94588, USA., Devgan G; Pfizer Oncology, New York, NY 10017, USA., Tan W; Pfizer Clinical Pharmacology, San Diego, CA 92121, USA., Quinn S; Pfizer Oncology, Cambridge, MA 02139, USA., Wang T; Pfizer Oncology, Groton, CT 06340, USA., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China.
Source: Future oncology (London, England) [Future Oncol] 2019 Aug; Vol. 15 (24), pp. 2795-2805. Date of Electronic Publication: 2019 Jul 17.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31313942
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Corral+J%22">Corral J</searchLink>; Clínica Universidad de Navarra, Madrid, 28027, Spain.<br /><searchLink fieldCode="AU" term="%22Mok+TS%22">Mok TS</searchLink>; State Key Laboratory of South China, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, PR China.<br /><searchLink fieldCode="AU" term="%22Nakagawa+K%22">Nakagawa K</searchLink>; Kindai University Hospital, Osaka, 589-8511, Japan.<br /><searchLink fieldCode="AU" term="%22Rosell+R%22">Rosell R</searchLink>; Catalan Institute of Oncology, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Lee+KH%22">Lee KH</searchLink>; Chungbuk National University Hospital, Cheongju, Korea.<br /><searchLink fieldCode="AU" term="%22Migliorino+MR%22">Migliorino MR</searchLink>; Pulmonary Oncology Unit, San Camillo-Forlanini Hospital, Rome, 00152, Italy.<br /><searchLink fieldCode="AU" term="%22Pluzanski+A%22">Pluzanski A</searchLink>; The Maria Sklodowska-Curie Memorial Cancer Centre & Institute of Oncology, Warsaw, 02-781, Poland.<br /><searchLink fieldCode="AU" term="%22Linke+R%22">Linke R</searchLink>; SFJ Pharmaceuticals®, Pleasanton, CA 94588, USA.<br /><searchLink fieldCode="AU" term="%22Devgan+G%22">Devgan G</searchLink>; Pfizer Oncology, New York, NY 10017, USA.<br /><searchLink fieldCode="AU" term="%22Tan+W%22">Tan W</searchLink>; Pfizer Clinical Pharmacology, San Diego, CA 92121, USA.<br /><searchLink fieldCode="AU" term="%22Quinn+S%22">Quinn S</searchLink>; Pfizer Oncology, Cambridge, MA 02139, USA.<br /><searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; Pfizer Oncology, Groton, CT 06340, USA.<br /><searchLink fieldCode="AU" term="%22Wu+YL%22">Wu YL</searchLink>; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, PR China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101256629%22">Future oncology (London, England)</searchLink> [Future Oncol] 2019 Aug; Vol. 15 (24), pp. 2795-2805. <i>Date of Electronic Publication: </i>2019 Jul 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101256629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8301 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214796694%22">14796694 </searchLink><i>NLM ISO Abbreviation: </i>Future Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31313942
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2217/fon-2019-0299
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2795
    Titles:
      – TitleFull: Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Corral J
      – PersonEntity:
          Name:
            NameFull: Mok TS
      – PersonEntity:
          Name:
            NameFull: Nakagawa K
      – PersonEntity:
          Name:
            NameFull: Rosell R
      – PersonEntity:
          Name:
            NameFull: Lee KH
      – PersonEntity:
          Name:
            NameFull: Migliorino MR
      – PersonEntity:
          Name:
            NameFull: Pluzanski A
      – PersonEntity:
          Name:
            NameFull: Linke R
      – PersonEntity:
          Name:
            NameFull: Devgan G
      – PersonEntity:
          Name:
            NameFull: Tan W
      – PersonEntity:
          Name:
            NameFull: Quinn S
      – PersonEntity:
          Name:
            NameFull: Wang T
      – PersonEntity:
          Name:
            NameFull: Wu YL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2019 Aug
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1744-8301
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 24
          Titles:
            – TitleFull: Future oncology (London, England)
              Type: main
ResultId 1